Demonstrates rapid identification of colistin-resistant E. cloacae complex, suggesting improved therapy and control.
High Resolution Image Download MS PowerPoint Slide The Enterobacter cloacae complex (ECC) comprises major nosocomial pathogens and is increasingly resistant to last-line agents such as colistin. Here, we developed a rapid workflow that integrates negative-ion mode MALDI-TOF mass spectrometry with machine learning to identify colistin-resistant ECC (COL-R-ECC). We analyzed 267 clinical ECC isolates; species identification was performed by MALDI-TOF MS and verified by whole-genome sequencing. A one-dimensional convolutional neural network (1D-CNN) with a squeeze-and-excitation (SE) module was trained on spectra from 217 isolates and evaluated on an independent external cohort of 50 isolates. To enhance analytical specificity, we applied a standardized lipid extraction protocol and focused on lipid A–enriched signals ( m / z 1500–3000). Spectra were binned at 0.1 Da and smoothed using a Savitzky–Golay filter. The optimized model achieved 95.5% accuracy (AUROC = 0.986; F1 = 0.943) in internal testing and 96.0% accuracy (F1 = 0.960) in external validation, outperforming conventional machine-learning baselines. SHAP analysis highlighted 30 lipid-associated features that contributed most to the predictions, providing interpretable clues to potential resistance mechanisms. Overall, this workflow enables COL-R-ECC identification within ∼1 h from colony processing, substantially faster than standard susceptibility testing, and may support earlier targeted therapy and infection control.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: